Lipid supplements reduce the risk of severe retinopathy of prematurity

The Mega Donna Mega study is now published in JAMA Pediatrics. This Swedish randomized clinical trial has showed that enteral supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA) reduced the risk of severe retinopathy of prematurity (ROP) by 50% in extremely preterm infants. In addition, the group that received enteral AA and DHA supplementation […]

Read More